This startup develops rapid microbial detection systems for the pharmaceutical industry. Their digital solutions enable faster identification of microorganisms in pharmaceutical products, reducing testing times and improving patient safety.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional microbial detection methods in the pharmaceutical industry can be time-consuming, leading to delays in product release and potential risks to patient safety. Extended testing periods increase manufacturing cycle times and can hinder the timely delivery of essential medications.
Solution
Biotactical Solutions offers rapid microbial detection systems designed to accelerate the identification of microorganisms in pharmaceutical products. Their digital solutions leverage advanced technology and software to significantly reduce testing times, enabling faster release of safe and effective medications. By streamlining the detection process, Biotactical Solutions helps pharmaceutical manufacturers improve operational efficiency, reduce patient waiting times, and ensure adherence to stringent quality standards. The company's offerings include rapid microbial detection devices, quality assurance testing services, and software and data analytics services.
Target Audience
The primary target audience includes pharmaceutical manufacturers and healthcare facilities seeking to improve the speed and accuracy of microbial detection in pharmaceutical products.
Features
- Rapid microbial detection devices for immediate and precise microorganism identification.
- Quality assurance testing services to ensure products meet industry standards.
- Software and data analytics services for optimized processes and strategic decision-making.
- Training and consultation services providing expertise on regulatory compliance and best practices.
- Microbial detection within 48 hours.